Anyone see this on the 25th? Medifast initiated with "outperform"
Monday, September 25, 2006 7:42:39 AM ET
Ryan, Beck & Co
NEW YORK, September 25 (newratings.com) - Analyst Mark Rupe of Ryan Beck & Co initiates coverage of Medifast Inc (MDF.ETR) with an "outperform" rating. The target price is set to $11.
In a research note published this morning, the analyst mentions that the company is expected to be able to generate 20%-30% revenue and EPS growth per annum for the next several years. Growth in the near term is likely to be driven mostly by Medifast’s direct-to-consumer and network marketing channels, with an increase in media spend, the analyst says. The company is also expected to witness continued growth in its weight loss business, Ryan Beck & Co adds.